These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34242472)

  • 1. Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects.
    Abbas R; Riley S; Nepal S; Bachinsky M; Lee KC; Chappell PB; Damle B
    Clin Pharmacol Drug Dev; 2022 Jan; 11(1):100-111. PubMed ID: 34242472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects.
    Abbas R; Riley S; LaBadie RR; Bachinsky M; Chappell PB; Crownover PH; Damle B
    Clin Pharmacol Drug Dev; 2020 Apr; 9(3):307-320. PubMed ID: 31777203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects.
    Zhou D; So K; Dymond AW; Vik T; Al-Huniti N; Mariani G; Zorenyi G; Huang Y; Holmes V; Severin P; Rasmussen S; Martin P
    Clin Ther; 2016 Dec; 38(12):2555-2566. PubMed ID: 27837934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
    Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
    Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thorough QT/QTc study of the effect of fasiglifam, a GPR40 agonist, on cardiac repolarization in healthy adults.
    Lee RD; Nudurupati S; Marcinak J; Viswanathan P
    Clin Pharmacol Drug Dev; 2015; 4(3):175-83. PubMed ID: 27140797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
    Zhang W; Smulders R; Abeyratne A; Dietz A; Krauwinkel W; Kadokura T; Keirns J
    Clin Ther; 2013 Aug; 35(8):1150-1161.e3. PubMed ID: 23910665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.
    de Kam PJ; van Kuijk J; Lillin O; Post T; Thomsen T
    Clin Drug Investig; 2014 Jun; 34(6):413-20. PubMed ID: 24777591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-QTcF Modeling of Icenticaftor from a Randomized, Placebo- and Positive-Controlled Thorough QT Study in Healthy Participants.
    Iyer GR; Darpo B; Xue H; Lecot J; Zack J; Bebrevska L; Weis W; Jones I; Drollmann A
    Clin Pharmacol Drug Dev; 2024 May; 13(5):572-584. PubMed ID: 38284433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
    Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
    Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preladenant, a selective adenosine A₂A receptor antagonist, is not associated with QT/QTc prolongation.
    Wang Z; Xuan F; Lin WH; Troyer MD; Tendolkar A; Cutler DL
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1761-7. PubMed ID: 23857248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
    Sechaud R; Dumortier T; Balez S
    Int J Clin Pharmacol Ther; 2009 May; 47(5):321-7. PubMed ID: 19473594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Double-Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers.
    Lee J; Lester R; O'Reilly T; Lowe ER; Slatkin NE; Franklin H; Israel RJ
    Clin Pharmacol Drug Dev; 2023 Mar; 12(3):236-248. PubMed ID: 36708138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Double-Blind, Placebo- and Positive-Controlled, Three-Way Crossover Study in Healthy Participants to Investigate the Effect of Savolitinib on the QTc Interval.
    Sahota T; Dota CD; Vik T; Yan W; Verheijen RB; Walker S; Li Y; Goldwater R; Ghiorghiu D; Mellemgaard A; Ahmed GF
    Clin Pharmacol Drug Dev; 2021 May; 10(5):521-534. PubMed ID: 33400845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT/QTc study conducted in healthy volunteers.
    Donazzolo Y; Latreille M; Caillaud MA; Mocaer E; Seguin L
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):440-51. PubMed ID: 24977347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults.
    Newman LM; Kankam M; Nakamura A; Conrad T; Mueller J; O'Donnell J; Osborn BL; Gu K; Saviolakis GA
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0129221. PubMed ID: 34606332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study.
    Pinto R; l'Hostis P; Patat A; Homery MC; Falcão A; Nunes T; Rocha JF; Soares-da-Silva P
    Clin Pharmacol Drug Dev; 2015 Nov; 4(6):454-62. PubMed ID: 27137718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Thorough QT Study of the Combination Glecaprevir + Pibrentasvir on Cardiac Repolarization in Healthy Subjects.
    Oberoi RK; Zhao W; Rosebraugh M; Mensa F; Wang H; Liu W
    Clin Ther; 2020 Jul; 42(7):1317-1329. PubMed ID: 32622784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thorough QT/QTc Study Evaluating the Effect of Macimorelin on Cardiac Safety Parameters in Healthy Participants.
    Lissy M; Demmel V; Sachse R; Ammer N; Kelepouris N; Ostrow V
    Clin Pharmacol Drug Dev; 2021 May; 10(5):494-501. PubMed ID: 32961034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056).
    Ufer M; Sagkriotis A; Salunke A; Ganesan S; Tisserant A; Dodman A; Voltz E; Woessner R; Jordaan P; Legangneux E
    Clin Ther; 2016 Dec; 38(12):2589-2597. PubMed ID: 27823869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.